View Article

Abstract

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to impaired insulin secretion, insulin action, or both. [1] With the global rise in diabetic populations, especially in developing countries, there is growing interest in exploring cost-effective and safer alternatives to synthetic antidiabetic drugs. Herbal medicines have gained attention for their long-standing use, minimal side effects, and holistic benefits in managing blood glucose levels. This review focuses on the antidiabetic potential of commonly used medicinal plants such as Neem (Azadirachta indica), Turmeric (Curcuma longa), Cinnamon (Cinnamomum verum), Fenugreek (Trigonella foenum-graecum), Bitter melon (Momordica charantia), and Jamun (Syzygium cumini)[29].These plants exert hypoglycemic effects through various mechanisms, including enhancing insulin secretion, improving insulin sensitivity, inhibiting carbohydrate-digesting enzymes, and protecting pancreatic ?-cells. The review also discusses traditional usage, phytochemical constituents, suggested methods of administration, and recent scientific findings supporting their efficacy. In addition, the future scope of integrating herbal therapies with conventional treatment protocols for better glycemic control is explored.

Keywords

Diabetes mellitus, Herbal antidiabetic therapies, Medicinal plants, Azadirachta indica, Curcuma longa, Cinnamomum verum, Trigonella foenum-graecum, Insulin sensitivity, Glycemic control

Introduction

× Popup Image

Diabetes mellitus is one of the most prevalent chronic metabolic disorders affecting millions globally. It is primarily characterized by persistent hyperglycemia resulting from insulin deficiency, insulin resistance, or both. As of 2024, the International Diabetes Federation (IDF) reports that over 537 million adults worldwide are living with diabetes—a number projected to rise drastically over the coming decades.[2]

While conventional treatment options such as insulin therapy and oral hypoglycemic drugs play a significant role in glycemic control, they are often associated with long-term side effects, high costs, and patient compliance issues. In this context, the search for safer, cost-effective, and sustainable alternatives has led to renewed interest in traditional and herbal medicine systems.

For centuries, medicinal plants have been used across diverse cultures for managing various ailments, including diabetes. Numerous herbs have demonstrated antidiabetic effects through multiple mechanisms such as enhancing insulin secretion, improving glucose uptake, reducing oxidative stress, and preserving pancreatic β-cell function. This review highlights major antidiabetic medicinal plants, their phytochemicals, modes of action, and clinical evidence supporting their efficacy.

Pathophysiology of Diabetes and the Role of Herbal Intervention

Diabetes mellitus is a chronic metabolic disorder primarily categorized into Type 1 (T1DM) and Type 2 (T2DM). Type 1 is characterized by autoimmune destruction of pancreatic β-cells, leading to an absolute insulin deficiency. In contrast, Type 2 diabetes involves a combination of insulin resistance and inadequate insulin secretion.

The pathophysiology of T2DM involves multiple defects:

Impaired insulin action in peripheral tissues (muscle and adipose)

Increased hepatic glucose production

β-cell dysfunction

Inflammation and oxidative stress[3]

 

 

These metabolic abnormalities lead to chronic hyperglycemia and the development of microvascular and macrovascular complications, such as nephropathy, neuropathy, retinopathy, and cardiovascular diseases.[4,5]

Herbal medicines provide therapeutic potential through multiple pathways that can counteract these dysfunctions. Some of the well-established mechanisms by which herbal extracts exert antidiabetic effects include:

Mechanisms of Herbal Action in Diabetes:

Sr.no

Biological Source of herbal drugs

Mechanism of action

Description

1

Neem (Azadirachta indica) obtained from leaves and seeds of Azadirachta indica belonging to Family Meliaceae[6]

Stimulates insulin secretion, improves insulin sensitivity, and reduces oxidative stress.[9]

Herbs that act like insulin to promote glucose uptake

2

Turmeric (Curcuma longa) –obtained from Dried rhizomes of Curcuma longa belonging to Family Zingiberaceae[11]

Improves insulin sensitivity, reduces inflammation and oxidative stress, and protects pancreatic β-cells.[13]

Stimulate pancreatic β-cells to release insulin

3

Cinnamon (Cinnamomum verum) obtained from Dried inner bark of Cinnamomum verum belonging to Family: Lauraceae[16]

Exhibits insulin-mimetic activity, enhances glucose uptake, and inhibits α-glucosidase enzyme[18]

Inhibit α-glucosidase and α-amylase to delay carbohydrate absorption

4

Fenugreek (Trigonella foenum-graecum) – obtained from ripe seeds of Trigonella foenum-graecum belonging to Family: Fabaceae[21]

Stimulates insulin secretion, delays glucose absorption, and improves insulin receptor sensitivity.[23]

Neutralize oxidative stress and protect β-cells        

5

Bitter Melon (Momordica charantia)  obtained from Fresh fruits and seeds of Momordica charantia belonging to Family Cucurbitaceae[26]

Possesses insulin-like activity, enhances peripheral glucose uptake, and inhibits gluconeogenesis.[28]    

Enhance insulin receptor response in cells

6

Jamun (Syzygium cumini)  obtained from Seeds and fruits of Syzygium cumini belonging to Family Myrtaceae[31]

Regulates insulin activity, delays carbohydrate absorption, and provides antioxidant protection to pancreatic β-cells.[33]

Providing decreased effects of insulin while decreasing absorption.

These multiple targets make plant-based treatments promising for integrated diabetes management, especially in early or moderate stages of the drugs involved in Diabetes

Key Herbal Plants Used in Diabetes Management

Sr no

Name

Active Constituents

Role in Diabetes Management

Dosage forms

1

Neem

(Azadirachta indica

 

 

 

 

Nimbin, Azadirachtin

Stimulates insulin secretion, reduces blood glucose levels, exhibits antioxidant activity, improves insulin sensitivity

 

Capsule

 

 

2

Turmeric (Curcuma longa)

 

 

 

Curcumin

Improves insulin sensitivity, reduces inflammation and oxidative stress, protects pancreatic β-cells

Capsules

 

 

3

Cinnamon (Cinnamomum verum)

 

 

 

Cinnamaldehyde

Mimics insulin action, enhances glucose uptake, inhibits α-glucosidase, lowers postprandial glucose

Powder, capsules, tea, extracts

Powder

 

 

4

 


Fenugreek (Trigonella foenum-graecum)

 

 

4-Hydroxyisoleucine

Stimulates insulin release, delays carbohydrate absorption, improves glucose tolerance

Seeds, powder, capsules

 


Powder

 

5

 


Bitter Melon (Momordica charantia)

 

Charantin, Polypeptide-P

Exhibits insulin-like activity, enhances glucose uptake, reduces blood glucose levels

 


Liquid

 

6

 


Jamun (Syzygium cumini)

 

 

Jamboline, Ellagic acid,Anthocynins

 

Delays glucose absorption, improves insulin activity, protects against diabetic complications

 


Powder

 

Clinical Evidence of Herbal Efficacy in Diabetes Clinical Studies

Clinical Evidence of Herbal Efficacy in Diabetes Clinical Studies Supporting Herbal Antidiabetic Therapies Several herbs used in traditional medicine systems have progressed from lab research to human clinical trials. Below are examples of clinical studies that validate the efficacy of the herbs discussed:-

Herb (Scientific name)

Study design

Dose and duration

Key findings

Author and year

References number

Neem (Azadirachta indica)

Randomized clinical trial in Type 2 diabetic patients

500 mg neem leaf extract twice daily for 12 weeks

Significant reduction in fasting blood glucose (FBG) and HbA1c levels; improved lipid profile; no major adverse effects reported.

Usharani pingali,Mohammed abid ali,et.al

2020

 

[7]

Turmeric (Curcuma longa)

 

Double-blind placebo-controlled study

1500 mg curcumin daily for 3 months

Improved HbA1c, fasting blood glucose, and insulin sensitivity; reduced oxidative stress and inflammatory markers.

Ledyane Taynara Marton et al. Front Endocrinol (Lausanne). 2021.

[12]

Cinnamon (Cinnamomum verum)

Meta-analysis of 16 clinical trials

1–6 g/day for 40–90 days

Reduced fasting blood glucose, HbA1c, and triglyceride levels in patients with Type 2 diabetes mellitus.

Amir Hossein Moridpour et al. Phytother Res. 2024 Jan

[17]

Fenugreek (Trigonella foenum-graecum

Clinical trials

 

25 g seed powder/day

Improved glucose tolerance, reduced insulin resistance, and lowered cholesterol and triglyceride levels

Melina Haxhiraj et al. Int J Mol Sci. 2024.

[22]

Bitter Melon (Momordica charantia

Placebo-controlled clinical study

50 mL juice/day for 12 weeks

Reduced postprandial blood glucose levels and enhanced insulin secretion.

Soo Kyoung Kim et al. Complement Ther Med. 2020 Aug.

[27]

Jamun (Syzygium cumini)

Clinical trial

5 g seed powder twice daily for 3 months

Improved glycemic control, reduced symptoms such as polyuria and fatigue, and demonstrated good safety and tolerability.

Venkatramanan Varadharajan et al. Bioorg Chem. 2025.

[32]

Future Scope & Research Opportunities

Despite promising clinical results, several gaps remain:

Standardization: Variation in extraction methods, dosages, and phytochemical content affects reproducibility

Long-Term Trials: Most studies are short-duration. Large-scale, long-term trials are needed.

Herb-Drug Interactions: Detailed research is required on interactions with insulin or oral antidiabetics.

Formulation Development: Combining multiple herbs in synergistic formulations (polyherbal capsules, teas, or nan carriers) can enhance efficacy.

Integration into Modern Medicine: Incorporating validated herbal treatments into primary healthcare systems can reduce dependence on synthetic drugs and improve accessibility in rural areas.

The global burden of diabetes continues to rise, necessitating safer, more accessible, and cost-effective treatment options. Herbal medicines offer promising alternatives or adjuncts to conventional therapy. With diverse mechanisms such as insulin mimetic activity, β-cell protection, enzyme inhibition, and antioxidant effects, herbs like Neem, Turmeric, Cinnamon, Fenugreek, Bitter Melon, and Jamun have shown significant antidiabetic potential.

Multiple clinical studies have confirmed their ability to reduce fasting and postprandial blood sugar, lower HbA1c levels, and improve insulin sensitivity with minimal side effects. These plant-based therapies not only target hyperglycemia but may also prevent complications associated with long-term diabetes.

CONCLUSION

The global burden of diabetes continues to rise, necessitating safer, more accessible, and cost-effective treatment options. Herbal medicines offer promising alternatives or adjuncts to conventional therapy. With diverse mechanisms such as insulin mimetic activity, β-cell protection, enzyme inhibition, and antioxidant effects, herbs like Neem, Turmeric, Cinnamon, Fenugreek, Bitter Melon, and Jamun have shown significant antidiabetic potential.

Multiple clinical studies have confirmed their ability to reduce fasting and postprandial blood sugar, lower HbA1c levels, and improve insulin sensitivity with minimal side effects. These plant-based therapies not only target hyperglycemia but may also prevent complications associated with long-term diabetes.

How to Use These Herbs (Traditional & Clinical Forms)

No.

Herb

Traditional form

Clinical form

References number

1

Neem

Neem leaf juice or powder

500mg neem extract capsules daily

[8,10]

2

Turmeric

Mixed in warm milk,powder in food

1500mg curcumin/day

[13,15]

3

Cinnamon

Powder with water/tea

1 to 6 grams/day as capsule or added to diet

[18,20]

4

Fenugreek

Soaked seeds or powder

25 grams seed powder/day

[23,25]

5

Bitter melon

Juice,curry, capsule

50ml juice/day or 2 to 3 capsules daily

[27,29]

6

Jamun

Seed powder,fruit juice

5g seed powder twice a day after meals

[33,35]

REFERENCES

  1. Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: An overview. Avicenna J Med. 2020 Oct 13;10(4):174-188. Doi: 10.4103/ajm.ajm_53_20. PMID: 33437689; PMCID: PMC7791288.
  2. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021. Available from: https://diabetesatlas.org⁠�
  3. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martín C. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020 Aug 30;21(17):6275. Doi: 10.3390/ijms21176275. PMID: 32872570; PMCID: PMC7503727.
  4. Singh A, Shadangi S, Gupta PK, Rana S. Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies. Compr Physiol. 2025 Feb;15(1):e70003. Doi: 10.1002/cph4.70003. PMID: 39980164.
  5. Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. Adv Exp Med Biol. 2012;771:1-11. Doi: 10.1007/978-1-4614-5441-0_1. PMID: 23393665.
  6. Vidhya Rekha U, Anita M, Bhuminathan S, Sadhana K. Known data on the therapeutic use of Azadiracta indica (neem) for type 2 diabetes mellitus. Bioinformation. 2022 Feb 28;18(2):82-87. Doi: 10.6026/97320630018082. PMID: 36420434; PMCID: PMC9649496.
  7. Shashank M Patil, Prithvi S Shirahatti, Ramith Ramu, Azadirachta indica A. Juss (neem) against diabetes mellitus: a critical review on its phytochemistry, pharmacology, and toxicology, Journal of Pharmacy and Pharmacology, Volume 74, Issue 5, May 2022, Pages 681–710, https://doi.org/10.1093/jpp/rgab098
  8. Pingali U, Ali MA, Gundagani S, Nutalapati C. Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study. Diabetes Metab Syndr Obes. 2020 Nov 17;13:4401-4412. Doi: 10.2147/DMSO.S274378. PMID: 33244247; PMCID: PMC7683773.
  9. Alzohairy MA. Therapeutics Role of Azadirachta indica (Neem) and Their Active Constituents in Diseases Prevention and Treatment. Evid Based Complement Alternat Med. 2016;2016:7382506. Doi: 10.1155/2016/7382506. Epub 2016 Mar 1. PMID: 27034694; PMCID: PMC4791507.
  10. An overview of Neem (Azadirachta indica) and its potential impact on health by jose Francisco etlashttps://www.sciencedirect.com/science/article/pii/S1756464620303959
  11. Mokgalaboni K, Mashaba RG, Phoswa WN, Lebelo SL. Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial. Nutrients. 2024 Nov 30;16(23):4177. Doi: 10.3390/nu16234177. PMID: 39683570; PMCID: PMC11644433.
  12. Yaikwawong M, Jansarikit L, Jirawatnotai S, Chuengsamarn S. Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial. Nutr J. 2024 Oct 1;23(1):119. Doi: 10.1186/s12937-024-01022-3. PMID: 39354480; PMCID: PMC11445938.
  13. Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017 Oct 22;6(10):92. Doi: 10.3390/foods6100092. PMID: 29065496; PMCID: PMC5664031.
  14. Marton LT, Pescinini-E-Salzedas LM, Camargo MEC, Barbalho SM, Haber JFDS, Sinatora RV, Detregiachi CRP, Girio RJS, Buchaim DV, Cincotto Dos Santos Bueno P. The Effects of Curcumin on Diabetes Mellitus: A Systematic Review. Front Endocrinol (Lausanne). 2021 May 3;12:669448. Doi: 10.3389/fendo.2021.669448. PMID: 34012421; PMCID: PMC8126655.
  15. Urošević M, Nikolić L, Gajić I, Nikolić V, Dinić A, Miljković V. Curcumin: Biological Activities and Modern Pharmaceutical Forms. Antibiotics (Basel). 2022 Jan 20;11(2):135. Doi: 10.3390/antibiotics11020135. PMID: 35203738; PMCID: PMC8868220.
  16. Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. Evid Based Complement Alternat Med. 2014;2014:642942. Doi: 10.1155/2014/642942. Epub 2014 Apr 10. PMID: 24817901; PMCID: PMC4003790.
  17. Moridpour AH, Kavyani Z, Khosravi S, Farmani E, Daneshvar M, Musazadeh V, Faghfouri AH. The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2024 Jan;38(1):117-130. Doi: 10.1002/ptr.8026. Epub 2023 Oct 11. PMID: 37818728.
  18. Silva ML, Bernardo MA, Singh J, de Mesquita MF. Cinnamon as a Complementary Therapeutic Approach for Dysglycemia and Dyslipidemia Control in Type 2 Diabetes Mellitus and Its Molecular Mechanism of Action: A Review. Nutrients. 2022 Jul 5;14(13):2773. Doi: 10.3390/nu14132773. PMID: 35807953; PMCID: PMC9269353.
  19. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003 Dec;26(12):3215-8. Doi: 10.2337/diacare.26.12.3215. PMID: 14633804.
  20. Ranasinghe P, Galappaththy P, Constantine GR, Jayawardena R, Weeratunga HD, Premakumara S, Katulanda P. Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial. Trials. 2017 Sep 29;18(1):446. Doi: 10.1186/s13063-017-2192-0. PMID: 28962661; PMCID: PMC5622575.
  21. Luo W, Deng J, He J, Yin L, You R, Zhang L, Shen J, Han Z, Xie F, He J, Guan Y. Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi-target pharmacology of fenugreek against diabetes. J Cell Mol Med. 2023 Jul;27(14):1959-1974. Doi: 10.1111/jcmm.17787. Epub 2023 May 31. PMID: 37257051; PMCID: PMC10339091.
  22. Cortez-Navarrete M, Pérez-Rubio KG, Escobedo-Gutiérrez MJ. Role of Fenugreek, Cinnamon, Curcuma longa, Berberine and Momordica charantia in Type 2 Diabetes Mellitus Treatment: A Review. Pharmaceuticals (Basel). 2023 Mar 30;16(4):515. Doi: 10.3390/ph16040515. PMID: 37111272; PMCID: PMC10145167.
  23. Haxhiraj M, White K, Terry C. The Role of Fenugreek in the Management of Type 2 Diabetes. Int J Mol Sci. 2024 Jun 26;25(13):6987. Doi: 10.3390/ijms25136987. PMID: 39000103; PMCID: PMC11240913.
  24. Kim J, Noh W, Kim A, Choi Y, Kim YS. The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Mol Sci. 2023 Sep 12;24(18):13999. Doi: 10.3390/ijms241813999. PMID: 37762302; PMCID: PMC10531284.
  25. Qiu D, Hu J, Zhang S, Cai W, Miao J, Li P, Jiang W. Fenugreek extract improves diabetes-induced endothelial dysfunction via the arginase 1 pathway. Food Funct. 2024 Apr 2;15(7):3446-3462. Doi: 10.1039/d3fo04283a. PMID: 38450419.
  26. Sur S, Ray RB. Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy. Cancers (Basel). 2020 Jul 27;12(8):2064. Doi: 10.3390/cancers12082064. PMID: 32726914; PMCID: PMC7464160.
  27. Kim SK, Jung J, Jung JH, Yoon N, Kang SS, Roh GS, Hahm JR. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus. Complement Ther Med. 2020 Aug;52:102524. Doi: 10.1016/j.ctim.2020.102524. Epub 2020 Jul 22. PMID: 32951763.
  28. Mahwish, Saeed F, Sultan MT, Riaz A, Ahmed S, Bigiu N, Amarowicz R, Manea R. Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment. Plants (Basel). 2021 Apr 8;10(4):730. Doi: 10.3390/plants10040730. PMID: 33918062; PMCID: PMC8070166.
  29. Cortez-Navarrete M, Pérez-Rubio KG, Escobedo-Gutiérrez MJ. Role of Fenugreek, Cinnamon, Curcuma longa, Berberine and Momordica charantia in Type 2 Diabetes Mellitus Treatment: A Review. Pharmaceuticals (Basel). 2023 Mar 30;16(4):515. Doi: 10.3390/ph16040515. PMID: 37111272; PMCID: PMC10145167.
  30. Hsu PK, Pan FFC, Hsieh CS. mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients’ Blood Sugar Levels. Nutrients. 2020 Apr 28;12(5):1252. Doi: 10.3390/nu12051252. PMID: 32354072; PMCID: PMC7281988.
  31. Das G, Nath R, Das Talukdar A, Ağagündüz D, Yilmaz B, Capasso R, Shin HS, Patra JK. Major Bioactive Compounds from Java Plum Seeds: An Investigation of Its Extraction Procedures and Clinical Effects. Plants (Basel). 2023 Mar 7;12(6):1214. Doi: 10.3390/plants12061214. PMID: 36986906; PMCID: PMC10057433
  32. Varadharajan V, Balu AK, Sinclair BJ, Perinbarajan GK, Jenifer A D, Ganesan Sudha H, Ramaswamy A, Venkidasamy B, Thiruvengadam M. Comprehensive analysis of Syzygium cumini L. pomace extract as an α-amylase inhibitor: In vitro inhibition, kinetics, and computational studies. Bioorg Chem. 2025 Jul 1;161:108498. Doi: 10.1016/j.bioorg.2025.108498. Epub 2025 May 2. PMID: 40339502.
  33. Ayyanar M, Subash-Babu P, Ignacimuthu S. Syzygium cumini (L.) Skeels., a novel therapeutic agent for diabetes: folk medicinal and pharmacological evidences. Complement Ther Med. 2013 Jun;21(3):232-43. Doi: 10.1016/j.ctim.2013.03.004. Epub 2013 Apr 25. PMID: 23642956.
  34. Stanely Mainzen Prince P, Kamalakkannan N, Menon VP. Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain. J Ethnopharmacol. 2003 Feb;84(2-3):205-9. Doi: 10.1016/s0378-8741(02)00316-1. PMID: 12648817.
  35. Benherlal PS, Arumughan C. Chemical composition and in vitro antioxidant studies on Syzygium cumini fruit. J Sci Food Agric. 2007 Nov;87(14):2560-9. Doi: 10.1002/jsfa.2957. PMID: 20836162.

Reference

  1. Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: An overview. Avicenna J Med. 2020 Oct 13;10(4):174-188. Doi: 10.4103/ajm.ajm_53_20. PMID: 33437689; PMCID: PMC7791288.
  2. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021. Available from: https://diabetesatlas.org??
  3. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martín C. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020 Aug 30;21(17):6275. Doi: 10.3390/ijms21176275. PMID: 32872570; PMCID: PMC7503727.
  4. Singh A, Shadangi S, Gupta PK, Rana S. Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies. Compr Physiol. 2025 Feb;15(1):e70003. Doi: 10.1002/cph4.70003. PMID: 39980164.
  5. Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. Adv Exp Med Biol. 2012;771:1-11. Doi: 10.1007/978-1-4614-5441-0_1. PMID: 23393665.
  6. Vidhya Rekha U, Anita M, Bhuminathan S, Sadhana K. Known data on the therapeutic use of Azadiracta indica (neem) for type 2 diabetes mellitus. Bioinformation. 2022 Feb 28;18(2):82-87. Doi: 10.6026/97320630018082. PMID: 36420434; PMCID: PMC9649496.
  7. Shashank M Patil, Prithvi S Shirahatti, Ramith Ramu, Azadirachta indica A. Juss (neem) against diabetes mellitus: a critical review on its phytochemistry, pharmacology, and toxicology, Journal of Pharmacy and Pharmacology, Volume 74, Issue 5, May 2022, Pages 681–710, https://doi.org/10.1093/jpp/rgab098
  8. Pingali U, Ali MA, Gundagani S, Nutalapati C. Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study. Diabetes Metab Syndr Obes. 2020 Nov 17;13:4401-4412. Doi: 10.2147/DMSO.S274378. PMID: 33244247; PMCID: PMC7683773.
  9. Alzohairy MA. Therapeutics Role of Azadirachta indica (Neem) and Their Active Constituents in Diseases Prevention and Treatment. Evid Based Complement Alternat Med. 2016;2016:7382506. Doi: 10.1155/2016/7382506. Epub 2016 Mar 1. PMID: 27034694; PMCID: PMC4791507.
  10. An overview of Neem (Azadirachta indica) and its potential impact on health by jose Francisco etlashttps://www.sciencedirect.com/science/article/pii/S1756464620303959
  11. Mokgalaboni K, Mashaba RG, Phoswa WN, Lebelo SL. Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial. Nutrients. 2024 Nov 30;16(23):4177. Doi: 10.3390/nu16234177. PMID: 39683570; PMCID: PMC11644433.
  12. Yaikwawong M, Jansarikit L, Jirawatnotai S, Chuengsamarn S. Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial. Nutr J. 2024 Oct 1;23(1):119. Doi: 10.1186/s12937-024-01022-3. PMID: 39354480; PMCID: PMC11445938.
  13. Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017 Oct 22;6(10):92. Doi: 10.3390/foods6100092. PMID: 29065496; PMCID: PMC5664031.
  14. Marton LT, Pescinini-E-Salzedas LM, Camargo MEC, Barbalho SM, Haber JFDS, Sinatora RV, Detregiachi CRP, Girio RJS, Buchaim DV, Cincotto Dos Santos Bueno P. The Effects of Curcumin on Diabetes Mellitus: A Systematic Review. Front Endocrinol (Lausanne). 2021 May 3;12:669448. Doi: 10.3389/fendo.2021.669448. PMID: 34012421; PMCID: PMC8126655.
  15. Uroševi? M, Nikoli? L, Gaji? I, Nikoli? V, Dini? A, Miljkovi? V. Curcumin: Biological Activities and Modern Pharmaceutical Forms. Antibiotics (Basel). 2022 Jan 20;11(2):135. Doi: 10.3390/antibiotics11020135. PMID: 35203738; PMCID: PMC8868220.
  16. Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. Evid Based Complement Alternat Med. 2014;2014:642942. Doi: 10.1155/2014/642942. Epub 2014 Apr 10. PMID: 24817901; PMCID: PMC4003790.
  17. Moridpour AH, Kavyani Z, Khosravi S, Farmani E, Daneshvar M, Musazadeh V, Faghfouri AH. The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2024 Jan;38(1):117-130. Doi: 10.1002/ptr.8026. Epub 2023 Oct 11. PMID: 37818728.
  18. Silva ML, Bernardo MA, Singh J, de Mesquita MF. Cinnamon as a Complementary Therapeutic Approach for Dysglycemia and Dyslipidemia Control in Type 2 Diabetes Mellitus and Its Molecular Mechanism of Action: A Review. Nutrients. 2022 Jul 5;14(13):2773. Doi: 10.3390/nu14132773. PMID: 35807953; PMCID: PMC9269353.
  19. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003 Dec;26(12):3215-8. Doi: 10.2337/diacare.26.12.3215. PMID: 14633804.
  20. Ranasinghe P, Galappaththy P, Constantine GR, Jayawardena R, Weeratunga HD, Premakumara S, Katulanda P. Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial. Trials. 2017 Sep 29;18(1):446. Doi: 10.1186/s13063-017-2192-0. PMID: 28962661; PMCID: PMC5622575.
  21. Luo W, Deng J, He J, Yin L, You R, Zhang L, Shen J, Han Z, Xie F, He J, Guan Y. Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi-target pharmacology of fenugreek against diabetes. J Cell Mol Med. 2023 Jul;27(14):1959-1974. Doi: 10.1111/jcmm.17787. Epub 2023 May 31. PMID: 37257051; PMCID: PMC10339091.
  22. Cortez-Navarrete M, Pérez-Rubio KG, Escobedo-Gutiérrez MJ. Role of Fenugreek, Cinnamon, Curcuma longa, Berberine and Momordica charantia in Type 2 Diabetes Mellitus Treatment: A Review. Pharmaceuticals (Basel). 2023 Mar 30;16(4):515. Doi: 10.3390/ph16040515. PMID: 37111272; PMCID: PMC10145167.
  23. Haxhiraj M, White K, Terry C. The Role of Fenugreek in the Management of Type 2 Diabetes. Int J Mol Sci. 2024 Jun 26;25(13):6987. Doi: 10.3390/ijms25136987. PMID: 39000103; PMCID: PMC11240913.
  24. Kim J, Noh W, Kim A, Choi Y, Kim YS. The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Mol Sci. 2023 Sep 12;24(18):13999. Doi: 10.3390/ijms241813999. PMID: 37762302; PMCID: PMC10531284.
  25. Qiu D, Hu J, Zhang S, Cai W, Miao J, Li P, Jiang W. Fenugreek extract improves diabetes-induced endothelial dysfunction via the arginase 1 pathway. Food Funct. 2024 Apr 2;15(7):3446-3462. Doi: 10.1039/d3fo04283a. PMID: 38450419.
  26. Sur S, Ray RB. Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy. Cancers (Basel). 2020 Jul 27;12(8):2064. Doi: 10.3390/cancers12082064. PMID: 32726914; PMCID: PMC7464160.
  27. Kim SK, Jung J, Jung JH, Yoon N, Kang SS, Roh GS, Hahm JR. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus. Complement Ther Med. 2020 Aug;52:102524. Doi: 10.1016/j.ctim.2020.102524. Epub 2020 Jul 22. PMID: 32951763.
  28. Mahwish, Saeed F, Sultan MT, Riaz A, Ahmed S, Bigiu N, Amarowicz R, Manea R. Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment. Plants (Basel). 2021 Apr 8;10(4):730. Doi: 10.3390/plants10040730. PMID: 33918062; PMCID: PMC8070166.
  29. Cortez-Navarrete M, Pérez-Rubio KG, Escobedo-Gutiérrez MJ. Role of Fenugreek, Cinnamon, Curcuma longa, Berberine and Momordica charantia in Type 2 Diabetes Mellitus Treatment: A Review. Pharmaceuticals (Basel). 2023 Mar 30;16(4):515. Doi: 10.3390/ph16040515. PMID: 37111272; PMCID: PMC10145167.
  30. Hsu PK, Pan FFC, Hsieh CS. mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients’ Blood Sugar Levels. Nutrients. 2020 Apr 28;12(5):1252. Doi: 10.3390/nu12051252. PMID: 32354072; PMCID: PMC7281988.
  31. Das G, Nath R, Das Talukdar A, A?agündüz D, Yilmaz B, Capasso R, Shin HS, Patra JK. Major Bioactive Compounds from Java Plum Seeds: An Investigation of Its Extraction Procedures and Clinical Effects. Plants (Basel). 2023 Mar 7;12(6):1214. Doi: 10.3390/plants12061214. PMID: 36986906; PMCID: PMC10057433
  32. Varadharajan V, Balu AK, Sinclair BJ, Perinbarajan GK, Jenifer A D, Ganesan Sudha H, Ramaswamy A, Venkidasamy B, Thiruvengadam M. Comprehensive analysis of Syzygium cumini L. pomace extract as an α-amylase inhibitor: In vitro inhibition, kinetics, and computational studies. Bioorg Chem. 2025 Jul 1;161:108498. Doi: 10.1016/j.bioorg.2025.108498. Epub 2025 May 2. PMID: 40339502.
  33. Ayyanar M, Subash-Babu P, Ignacimuthu S. Syzygium cumini (L.) Skeels., a novel therapeutic agent for diabetes: folk medicinal and pharmacological evidences. Complement Ther Med. 2013 Jun;21(3):232-43. Doi: 10.1016/j.ctim.2013.03.004. Epub 2013 Apr 25. PMID: 23642956.
  34. Stanely Mainzen Prince P, Kamalakkannan N, Menon VP. Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain. J Ethnopharmacol. 2003 Feb;84(2-3):205-9. Doi: 10.1016/s0378-8741(02)00316-1. PMID: 12648817.
  35. Benherlal PS, Arumughan C. Chemical composition and in vitro antioxidant studies on Syzygium cumini fruit. J Sci Food Agric. 2007 Nov;87(14):2560-9. Doi: 10.1002/jsfa.2957. PMID: 20836162.

Photo
Kunde Prachi
Corresponding author

Pravara Rural College of Pharmacy, Loni Tal. Rahata, Dist. Ahmednagar

Photo
Tapule Saloni
Co-author

Pravara Rural College of Pharmacy, Loni Tal. Rahata, Dist. Ahmednagar

Photo
Dalvi Deryani
Co-author

Pravara Rural College of Pharmacy, Loni Tal. Rahata, Dist. Ahmednagar

Kunde Prachi*, Tapule Saloni, Dalvi Deryani, Clinical Evidence Of Herbal Efficacy In Diabetes Clinical Studies Supporting Herbal Antidiabetic Therapies, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 7, 5056-5066. https://doi.org/10.5281/zenodo.21621642

More related articles
Navigating Cisplatin Toxicity in Cervical Cancer: ...
Dr. Swathi Boddupally , Mogilicharla Archana, Dornala Manoj, Nerm...
GoldenShield: A Petal-Powered Antioxidant Cream...
Dr. Ulka Aade, Nashra Bano, Sandhya Jaiswal, Priyanka Jha, Akisha...
Emerging Nanocrystals-Based Topical Delivery Syste...
Dr. Sankar.C , Dhanapriya S , Naresh Kumar S, Yokeshwaran S, Sneh...
Formulation And Evaluation of Herbal Sunscreen Cream: A Review...
Pranali Sonwane, Dr. Vijay Borkar, Dr G.V. Harlalka...
A Detail Review On White Analytical Chemistry (Wac) As A Comprehensive Framework...
Akshat Shah, Dr. C. N. Patel, Dr.Khushbu Patel, Prince G. Modi...
Related Articles
Single-Cell Multi-Omics and Cell-Type-Specific Molecular Mechanisms in Parkinson...
Anchal, Gaurav Hastir, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
Assessment of Chemotherapy-Induced Toxicities of FOLFOX Regimen in Pancreatic Ca...
Dr.swathi Boddupally , Dornala Manoj, Jarupla Mahika, Mogilicharla Archana, Nermetla Mahesh, Oddi Sa...
Toxicological Evaluation of Capox Regimen in Colorectal Cancer Therapy...
Dr. Swathi Boddupally, Dornala Manoj, Jarupla Mahika, Mogilicharla Archana, Oddi Sahithi, Nermetla M...
Ambispective Study of the Toxicological Profile of Cisplatin in Head and Neck Sq...
Dr. Swathi Boddupally, Jarupla Mahika, Dornala Manoj, Nermetla Mahesh, Oddi Sahithi, Mogilicharla Ar...
Navigating Cisplatin Toxicity in Cervical Cancer: Clinical Insights from a Case ...
Dr. Swathi Boddupally , Mogilicharla Archana, Dornala Manoj, Nermetla Mahesh, Oddi Sahithi, Jarupla ...
More related articles
Navigating Cisplatin Toxicity in Cervical Cancer: Clinical Insights from a Case ...
Dr. Swathi Boddupally , Mogilicharla Archana, Dornala Manoj, Nermetla Mahesh, Oddi Sahithi, Jarupla ...
GoldenShield: A Petal-Powered Antioxidant Cream...
Dr. Ulka Aade, Nashra Bano, Sandhya Jaiswal, Priyanka Jha, Akisha Irfan Sayed, Ghanshyam Kedar...
Emerging Nanocrystals-Based Topical Delivery Systems in Psoriasis Management: Ad...
Dr. Sankar.C , Dhanapriya S , Naresh Kumar S, Yokeshwaran S, Sneha R ...
Navigating Cisplatin Toxicity in Cervical Cancer: Clinical Insights from a Case ...
Dr. Swathi Boddupally , Mogilicharla Archana, Dornala Manoj, Nermetla Mahesh, Oddi Sahithi, Jarupla ...
GoldenShield: A Petal-Powered Antioxidant Cream...
Dr. Ulka Aade, Nashra Bano, Sandhya Jaiswal, Priyanka Jha, Akisha Irfan Sayed, Ghanshyam Kedar...
Emerging Nanocrystals-Based Topical Delivery Systems in Psoriasis Management: Ad...
Dr. Sankar.C , Dhanapriya S , Naresh Kumar S, Yokeshwaran S, Sneha R ...